Does Rallies show 13F holders for ALDX?

Yes. Rallies tracks hedge fund and 13F ownership data for ALDX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ALDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ALDX. It does not provide personalized investment advice.

ALDX (Aldeyra Therapeutics, Inc.) Stock Analysis - Hedge Fund Holdings

Aldeyra Therapeutics, Inc. (ALDX) is a publicly traded Healthcare sector company. As of May 21, 2026, ALDX trades at $1.52 with a market cap of $96.51M and a P/E ratio of -2.76. ALDX moved +0.00% today. Year to date, ALDX is -63.44%; over the trailing twelve months it is -34.32%. Its 52-week range spans $1.07 to $7.20. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces ALDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ALDX stock?

Hedge funds tracked by Rallies that own ALDX include Panagora Asset. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aldeyra Therapeutics, Inc..

ALDX Key Metrics

Key financial metrics for ALDX
Metric	Value
Price	$1.52
Market Cap	$96.51M
P/E Ratio	-2.76
EPS	$-0.56
Dividend Yield	0.00%
52-Week High	$7.20
52-Week Low	$1.07
Volume	22.76K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-33.85M
Gross Margin	0.00%

Top Hedge Funds Holding ALDX

Panagora Asset holds 72.06K shares of ALDX, changed +42.82% as of Jun 30, 2025.

Latest ALDX News

Aldeyra Therapeutics Shares Plunge 71% After Third FDA CRL on Reproxalap NDA — Mar 18, 2026
Aldeyra CEO Showcases Reproxalap Ahead of March 16 FDA PDUFA Decision — Feb 25, 2026

Recent ALDX Insider Trades

DOUGLAS RICHARD bought 70.00K (~$98.00K) on Mar 19, 2026.
Alfieri Michael bought 5.00K (~$7.10K) on Mar 18, 2026.
Alfieri Michael bought 2.50K (~$13.25K) on Aug 13, 2025.

ALDX Analyst Consensus

2 analysts cover ALDX: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.

Common questions about ALDX

Who owns ALDX stock?: Hedge funds tracked by Rallies that own ALDX include Panagora Asset. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aldeyra Therapeutics, Inc..
Does Rallies show 13F holders for ALDX?: Yes. Rallies tracks hedge fund and 13F ownership data for ALDX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ALDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ALDX. It does not provide personalized investment advice.